{"id":"W2113167936","doi":"10.1634/theoncologist.2011-0379","title":"Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer","year":2012,"lang":"en","type":"article","venue":"The Oncologist","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ministry of Health; Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Genentech; Canadian Cancer Society","keywords":"Medicine; Trastuzumab; Breast cancer; Regimen; Cost effectiveness; Oncology; Adjuvant; Quality of life (healthcare); Internal medicine; Quality-adjusted life year; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003683753,0.0001764974,0.0004834763,0.0001005442,0.00013847,0.00003087282,0.0003235161,0.00009049332,0.0002342809],"category_scores_gemma":[0.0001672331,0.0000922778,0.00009234797,0.0006641687,0.0007698597,0.0001548056,0.0001391694,0.0006671869,0.0000197376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002051971,"about_ca_system_score_gemma":0.0007719591,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01911408,"about_ca_topic_score_gemma":0.00360658,"domain_scores_codex":[0.9971842,0.001205555,0.0003151288,0.0002229184,0.0004759725,0.0005962775],"domain_scores_gemma":[0.9972757,0.001813074,0.0001470011,0.000469755,0.0001724568,0.0001220903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001741408,0.00119379,0.8300159,0.0004032752,0.0001907349,0.00007743621,0.002468967,0.0001878571,0.01620519,0.001119518,0.001146599,0.1452493],"study_design_scores_gemma":[0.001237807,0.0002025224,0.9898492,0.0006642818,0.00008364055,0.00006047906,0.001073248,0.000107039,0.005458059,0.00007198261,0.001086306,0.0001054905],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9572618,0.001092833,0.00005428918,0.005346323,0.0004184229,0.002204007,0.00007652309,0.00003705465,0.03350873],"genre_scores_gemma":[0.9981067,0.0002652777,0.00003764142,0.0002805963,0.0003623802,0.0004801342,0.000008917397,0.00003159313,0.0004268203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1598332,"threshold_uncertainty_score":0.9874177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1251169310672112,"score_gpt":0.4951463378981687,"score_spread":0.3700294068309575,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}